← Back to home

HYPERMETABOLIC LYMPHADENOPATHY MEDIASTINUM LOWER, POSTERIOR AND MIDDLE, DETECTED BY PET-CT WITH 18F-FDG (PET)

Clinical trials for HYPERMETABOLIC LYMPHADENOPATHY MEDIASTINUM LOWER, POSTERIOR AND MIDDLE, DETECTED BY PET-CT WITH 18F-FDG (PET) explained in plain language.

Never miss a new study

Get alerted when new HYPERMETABOLIC LYMPHADENOPATHY MEDIASTINUM LOWER, POSTERIOR AND MIDDLE, DETECTED BY PET-CT WITH 18F-FDG (PET) trials appear

Sign up with your email to follow new studies for HYPERMETABOLIC LYMPHADENOPATHY MEDIASTINUM LOWER, POSTERIOR AND MIDDLE, DETECTED BY PET-CT WITH 18F-FDG (PET), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New biopsy test aims to spare cancer patients from invasive surgery

Diagnosis Completed

This study tested a less invasive biopsy method for diagnosing suspicious lymph nodes found on PET scans in cancer patients. Researchers wanted to see if a guided needle biopsy, done through a tube in the throat, could accurately diagnose these lymph nodes. If successful, this me…

Matched conditions: HYPERMETABOLIC LYMPHADENOPATHY MEDIASTINUM LOWER, POSTERIOR AND MIDDLE, DETECTED BY PET-CT WITH 18F-FDG (PET)

Phase: NA • Sponsor: Institut Bergonié • Aim: Diagnosis

Last updated Mar 25, 2026 14:07 UTC

HYPERMETABOLIC LYMPHADENOPATHY MEDIASTINUM LOWER, POSTERIOR AND MIDDLE, DETECTED BY PET-CT WITH 18F-FDG (PET)

Get alerted when new HYPERMETABOLIC LYMPHADENOPATHY MEDIASTINUM LOWER, POSTERIOR AND MIDDLE, DETECTED BY PET-CT WITH 18F-FDG (PET) trials appear

New biopsy test aims to spare cancer patients from invasive surgery